For the year ending 2025-12-31, ENSC made $5,066,650 in revenue. -$10,175,700 in net income. Net profit margin of -200.84%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Federal grants | 5,066,650 | 5,210,031 | ||
| Research and development | 10,376,895 | 7,219,437 | ||
| General and administrative | 4,930,701 | 4,720,728 | ||
| Total operating expenses | 15,307,596 | 11,940,165 | ||
| Loss from operations | -10,240,946 | -6,730,134 | ||
| Change in fair value of liability classified warrants | 10,096 | 16,292 | ||
| Interest expense, net | 18,767 | 1,290,444 | ||
| Other income and expense, net | 73,430 | 17,277 | ||
| Total other income (expense), net | 64,759 | -1,256,875 | ||
| Net loss | -10,176,187 | -7,987,009 | ||
| Deemed dividend related to warrants down round provision | - | 290 | ||
| Net loss attributable to noncontrolling interests | -487 | -74 | ||
| Net loss attributable to common stockholders | -10,175,700 | -7,987,225 | ||
| Basic EPS | -3.98 | -11.45 | ||
| Diluted EPS | -3.98 | -11.45 | ||
| Basic Average Shares | 2,557,377 | 697,686 | ||
| Diluted Average Shares | 2,557,377 | 697,686 | ||
Ensysce Biosciences, Inc. (ENSC)
Ensysce Biosciences, Inc. (ENSC)